Results 271 to 280 of about 205,631 (301)
Some of the next articles are maybe not open access.

Incidental Prostate-Specific Membrane Antigen–Avid Vestibular Schwannoma Detected on 68Ga–Prostate-Specific Membrane Antigen PET/CT

Clinical Nuclear Medicine
Abstract A 62-year-old man was referred for a 68Ga–prostate-specific membrane antigen (PSMA) PET/CT scan for newly diagnosed prostate cancer (ISUP grade 5), on the background of left vestibular schwannoma treated with surgical excision 25 years ago.
Jeffrey, Chen   +3 more
openaire   +2 more sources

Prostate‐specific membrane antigen

British Journal of Urology, 1998
B H, Maraj, P, Whelan, A F, Markham
openaire   +2 more sources

Short-term Prostate-specific Antigen Pseudoregression Following [177Lu]–Prostate-specific Membrane Antigen Therapy

Clinical Nuclear Medicine
A 74-year-old man with metastatic castration-resistant prostate cancer underwent 2 cycles of [177Lu]Lu-prostate-specific membrane antigen (PSMA) therapy. Despite declining prostate-specific antigen (PSA) levels and pain relief throughout the first 4 months of [177Lu]Lu-PSMA therapy, follow-up [68Ga]Ga-PSMA PET/CT revealed progressive skeletal ...
Ahmed Saad Abdlkadir   +3 more
openaire   +1 more source

Prostate‐specific membrane antigen expressing angiolipoma

ANZ Journal of Surgery, 2020
Xuan Rui Sean Ong   +3 more
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

Overview of prostate-specific membrane antigen.

Reviews in urology, 2011
Efforts to evaluate and discover diagnostic and therapeutic markers for prostate cancer continue. One of these, prostate-specific membrane antigen (PSMA), a transmembrane protein expressed in all types of prostatic tissue, remains a useful diagnostic and possibly therapeutic target.
openaire   +1 more source

Prostate-specific Membrane Antigen

PET Clinics
Ian L. Alberts   +4 more
openaire   +2 more sources

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

Home - About - Disclaimer - Privacy